U.S. federal trademark · Serial No. 97703813
Pharmaceutical and therapeutic pharmaceutical preparations for the treatment and diagnosis of cancer and immunological diseases, disorders and conditions; pharmaceutical and therapeutic pharmaceutical preparations based on antibodies, namely, mono-, bi- and multi-specific antibodies, antigen binding fragments of the antibodies, and other targeting agents or conjugates of any of these for use with regard to the treatment and diagnosis of cancer, infectious, immune, autoimmune, and inflammatory diseases, disorders and conditions
Providing healthcare and medical information in the field of cancer and immunological diseases, disorders and conditions
Research and development of pharmaceuticals and therapeutic preparations for the treatment of mono-, bi- and multi-specific antibodies, antigen binding fragments of the antibodies, and other targeting agents or conjugates of any of these for use with regard to the treatment and diagnosis of cancer, infectious, immune, autoimmune, and inflammatory diseases, disorders and conditions; medical research services in the field of cancer and immunological diseases, disorders and conditions; clinical research in the field of cancer and immunological diseases, disorders and conditions
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.